Downregulation of pyrroline-5-carboxylate reductase-2 induces the autophagy of melanoma cells via AMPK/mTOR pathway
- 348 Downloads
Melanoma is the most aggressive form of skin cancer and causes 50,000 deaths annually worldwide. The roles of proline-dependent process and autophagy have both been reported in studies on melanoma. In the present study, we focused on the effect of pyrroline-5-carboxylate reductase-2 (PYCR2) on inducing autophagy process in melanoma. The expression of PYCR2 was regulated by an RNAi technique, and the cell proliferation of A375 cell line was determined by methyl thiazolyl tetrazolium test; the effect of PYCR2 on the apoptosis process and AMPK/mTOR pathway was evaluated by flow cytometry assay and Western blot. It was found that silence of PYCR2 resulted in the decrease of proliferative ability and activation of AMPK/mTOR-induced autophagy of A375 cells. PYCR2 silencing also activated AMPK/mTOR pathway in another melanoma cell line, CHL-1. However, the overexpression of PYCR2 seemed to make no difference to the cell viability and targeted pathway. Our results offered a preliminary illustration on the mechanism of the PYCR2-dependent autophagy and showed that PYCR2 was a potential therapeutic target of melanoma.
KeywordsMelanoma Pyrroline-5-carboxylate reductase-2 AMPK/mTOR Autophagy
This work was supported by grants from the National Natural Science Foundation of China (No. 81272987, 81373075, 81371748).
- 3.Corazzari M, Fimia GM, Lovat P, Piacentini M, editors. Why is autophagy important for melanoma? Molecular mechanisms and therapeutic implications 2013: Elsevier.Google Scholar
- 11.Rath M, Pauling L. Plasmin-induced proteolysis and the role of apoprotein (a), lysine and synthetic lysine analogs. J Orthomolecular Med. 1992;7(1):17–23.Google Scholar